<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05091762</url>
  </required_header>
  <id_info>
    <org_study_id>KY20210604-02</org_study_id>
    <nct_id>NCT05091762</nct_id>
  </id_info>
  <brief_title>Effect of Physiological Ischemic Training on Patients With Atherosclerosis</brief_title>
  <official_title>Effect of Physiological Ischemic Training on Patients With Atherosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing First Hospital, Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing First Hospital, Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study whether the resistance training with blood flow obstruction in patients in early&#xD;
      atherosclerosis period can produce a beneficial effect on preventing atherosclerosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelium dependent vasodilation</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of the change</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood lipid analysis results</measure>
    <time_frame>8 weeks</time_frame>
    <description>Content of total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The inflammatory state</measure>
    <time_frame>8 weeks</time_frame>
    <description>Content of NO, eNOS, iNOS, IFN-Î³, IL-6, IL-10 in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial repair function</measure>
    <time_frame>8 weeks</time_frame>
    <description>eNOSmRNA, iNOSmRNA, EPCs in blood</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Blank control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperlipidemia group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperlipidemia and medication group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperlipidemia and exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperlipidemia and medication and exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine treatment group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine treatment and exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise</intervention_name>
    <description>Upper limb resistance training with blood flow obstruction</description>
    <arm_group_label>Exercise group</arm_group_label>
    <arm_group_label>Hyperlipidemia and exercise group</arm_group_label>
    <arm_group_label>Hyperlipidemia and medication and exercise group</arm_group_label>
    <arm_group_label>Routine treatment and exercise group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. LDL &gt; 3.11mmol/l and less than 5.63mmol/l;&#xD;
&#xD;
          2. No serious heart, blood vessel and other related diseases;&#xD;
&#xD;
          3. There were no skeletal and muscular diseases affecting sports training;&#xD;
&#xD;
          4. No regular exercise in the past half year (no more than 2 times a week, no more than&#xD;
             30 minutes each time);&#xD;
&#xD;
          5. Smoking less than 1 pack / year, no history of drinking.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Haven't other serious heart and vascular diseases other than hyperlipidemia and / or&#xD;
             bones and muscles that affect sports training Diseases;&#xD;
&#xD;
          2. Pregnant women and people with disabilities;&#xD;
&#xD;
          3. Other circumstances determined by the researcher not suitable for the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aicui Lin, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing First Hospital, Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aicui Lin, PhD</last_name>
    <phone>+8615305179718</phone>
    <email>linaicui@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>JunXia Zhang, PhD</last_name>
    <phone>+8615850770739</phone>
    <email>15850770739@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aicui Lin, PhD</last_name>
      <phone>+8615305179718</phone>
      <email>linaicui@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing First Hospital, Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>linaicui</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>resistance training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

